德英生物科技
News

Events

2026.08.12

Events

G&E Biotechnology meets with overseas buyers

at Taiwan Health Industry Sourcing Day

 

We were delighted to connect with overseas buyers and industry professionals at the Taiwan Health Industry Sourcing Day organized by TAITRA. G&E’s enhanced silymarin innovation for international markets – HepaGent™ attracted strong attention and received highly positive feedback. We’re excited to continue exploring partnerships and welcome inquiries regarding international distribution opportunities.

Key Highlights of HepaGent™:

 Targeted support for liver repair, NAFLD, CKD, and blood sugar stabilization

Achieves up to 35× higher blood concentration compared to other commercial products

 92–99% dissolution rate, exceeding the USP ≥75% standard and outperforming global competitors

Formulated with no special excipients, fully compliant with global food regulations

 100% plant-based, suitable for vegetarians

#HepaGent #Liversolution #PharmaceuticalManufacturing #Botanicals #MadeinTaiwan #GnE #herbal #德英生技 #TAITRA